Plasma irisin levels in newly diagnosed leprosy patients: a case-control study

Area of Science:

• Immunology
• Endocrinology
• Neurology

Background:

• Leprosy is a granulomatous disease impacting skin, mucous membranes, and peripheral nerves.
• Irisin, a newly identified myokine, is implicated in inflammatory and metabolic conditions and found in nerve cells.
• Understanding irisin's role in leprosy pathogenesis is crucial for disease management.

Purpose of the Study:

• To compare plasma irisin levels between leprosy patients and healthy controls.
• To investigate the potential role of irisin in the pathogenesis of leprosy.
• To evaluate irisin as a potential biomarker for leprosy.

Main Methods:

• A case-control study involving 29 newly diagnosed leprosy patients and 29 healthy controls.
• Data collection included demographic information and disease history.
• Serum irisin levels were quantified using enzyme-linked immunosorbent assay (ELISA).

Main Results:

• Serum irisin levels were significantly lower in leprosy patients compared to healthy controls (p < 0.001).
• A notable difference in irisin levels was observed between the patient and control groups.
• Lower irisin levels indicate a potential association with leprosy.

Conclusions:

• Reduced serum irisin levels in leprosy patients suggest its involvement in the disease.
• Irisin may function as a potential biomarker for leprosy.
• Further research with larger sample sizes and longitudinal assessments is needed to confirm irisin's function and predictive value in leprosy.